KELSEY KELLY: Open Payments
NPI 1083135610 · FERDINAND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$149 in 8 payments from 7 companies in 2025. Trend: 2023 $170 · 2024 $167 · 2025 $149
Food & beverage: $149
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $17 |
| PFIZER INC. | 1 | $17 |
Products named: LEQVIO, KEVEYIS, Kerendia, JARDIANCE, Ozempic, NURTEC ODT, FARXIGA, BREZTRI.
Industry payments across IN — which companies pay providers there.
